Molecular imaging in oncology

Hybrid imaging and personalized therapy of cancer

George N Sfakianakis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner.However, the utilization of telomeres in clinical practice for patient evaluation is stillin the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of Molecular Imaging(MI) in the evaluation of oncologic patients.

Original languageEnglish (US)
Title of host publicationImaging in Clinical Oncology
PublisherSpringer-Verlag Milan
Pages3-11
Number of pages9
ISBN (Print)9788847053854, 9788847053847
DOIs
StatePublished - Jan 1 2014

Fingerprint

Multimodal Imaging
Molecular imaging
Molecular Imaging
Oncology
Telomere
Chromosomes
Imaging techniques
Neoplasms
Color
Mortality
Therapeutics
Survival

Keywords

  • Biomarker
  • Hybrid imaging
  • Molecular imaging
  • Personalized therapy
  • Telomeres

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Sfakianakis, G. N. (2014). Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer. In Imaging in Clinical Oncology (pp. 3-11). Springer-Verlag Milan. https://doi.org/10.1007/978-88-470-5385-4_1

Molecular imaging in oncology : Hybrid imaging and personalized therapy of cancer. / Sfakianakis, George N.

Imaging in Clinical Oncology. Springer-Verlag Milan, 2014. p. 3-11.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sfakianakis, GN 2014, Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer. in Imaging in Clinical Oncology. Springer-Verlag Milan, pp. 3-11. https://doi.org/10.1007/978-88-470-5385-4_1
Sfakianakis GN. Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer. In Imaging in Clinical Oncology. Springer-Verlag Milan. 2014. p. 3-11 https://doi.org/10.1007/978-88-470-5385-4_1
Sfakianakis, George N. / Molecular imaging in oncology : Hybrid imaging and personalized therapy of cancer. Imaging in Clinical Oncology. Springer-Verlag Milan, 2014. pp. 3-11
@inbook{821a777aa4ef447aaae430480ee5ccc5,
title = "Molecular imaging in oncology: Hybrid imaging and personalized therapy of cancer",
abstract = "It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner.However, the utilization of telomeres in clinical practice for patient evaluation is stillin the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of Molecular Imaging(MI) in the evaluation of oncologic patients.",
keywords = "Biomarker, Hybrid imaging, Molecular imaging, Personalized therapy, Telomeres",
author = "Sfakianakis, {George N}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-88-470-5385-4_1",
language = "English (US)",
isbn = "9788847053854",
pages = "3--11",
booktitle = "Imaging in Clinical Oncology",
publisher = "Springer-Verlag Milan",

}

TY - CHAP

T1 - Molecular imaging in oncology

T2 - Hybrid imaging and personalized therapy of cancer

AU - Sfakianakis, George N

PY - 2014/1/1

Y1 - 2014/1/1

N2 - It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner.However, the utilization of telomeres in clinical practice for patient evaluation is stillin the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of Molecular Imaging(MI) in the evaluation of oncologic patients.

AB - It has been proposed that the “telomeres” of the chromosomes, their four endpoints, determine our future: Harbingers of mortality, the telomeres at the chromosome tips glow brightly with appropriate color dying; they influence vulnerability, mortality, longevity, and survival. The longer the telomeres, the longer the person lives. If their length decreases, the person dies sooner.However, the utilization of telomeres in clinical practice for patient evaluation is stillin the distant future. At the present time, we can report that substantial advances have recently been achieved with the applications of Molecular Imaging(MI) in the evaluation of oncologic patients.

KW - Biomarker

KW - Hybrid imaging

KW - Molecular imaging

KW - Personalized therapy

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=84955739660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955739660&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-5385-4_1

DO - 10.1007/978-88-470-5385-4_1

M3 - Chapter

SN - 9788847053854

SN - 9788847053847

SP - 3

EP - 11

BT - Imaging in Clinical Oncology

PB - Springer-Verlag Milan

ER -